DiSanto Technology

New York, United States Founded: 1967 • Age: 59 yrs Acquired By Oerlikon
Contract manufacturer providing surgical implant using 3D printing technology

About DiSanto Technology

DiSanto Technology is a company based in New York (United States) founded in 1967 was acquired by Oerlikon in May 2018. The company has 76 employees. DiSanto Technology operates in a competitive market with competitors including Stryker, NuVasive, OssDsign, In'Tech Medical and CARLSMED, among others.

  • Headquarter New York, United States
  • Employees 76
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website disanto.com
  • Social LinkedIn
  • Acquired by Oerlikon (May 2018)
  • Legal Name Disanto Technology, Inc.
Key Metrics

Investors in DiSanto Technology

DiSanto Technology has secured backing from 2 investors. Prominent investors backing the company include Oerlikon and Arcam.

All
InvestorDescriptionFounded YearDomainLocation
Additive Manufacturing for Implants and Aerospace, EBM
1997arcam.comMolndal, Sweden
Powertrain systems and components are manufactured and supplied to OEMs.
1906oerlikon.comFreienbach, Switzerland
Premium access

Investor details for DiSanto Technology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of DiSanto Technology

3 dated milestones of DiSanto Technology across 51 years, from founding to its latest funding, stage changes and deals.

  1. Founded DiSanto Technology is founded.
  2. Exit Acquired by Arcam.
  3. Exit Acquired by Oerlikon.

Competitors of DiSanto Technology

DiSanto Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, NuVasive, OssDsign, In'Tech Medical and CARLSMED, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
stryker.com1941Kalamazoo, United States–25,035
3D-printed orthopedic products are manufactured for medical applications.
nuvasive.com1997San Diego, United States$54.1M2,450
Smart surgical devices for spinal surgery are developed.
ossdsign.com2011Uppsala, Sweden$19.75M–
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
intech-medical.com2000––271
Surgical instruments for orthopaedics are developed and manufactured.
carlsmed.com2018San Diego, United States$109.63M59
Developer of devices for spine surgery
4webmedical.com2008Frisco, United States$12.5M–
3D printed spinal implants
orthofix.com1980Lewisville, United States–1,634
Reconstructive and regenerative solutions for bone conditions are developed.
zavation.com2010Flowood, United States–110
Medical devices for spine surgery are designed, manufactured, and distributed.
arthrex.com1981Naples, United States–2,244
Orthopedic devices and arthroscopy education are developed by Arthrex.
Premium access

Detailed competitors of DiSanto Technology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to DiSanto Technology

10 companies that operate in the same segment as DiSanto Technology (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Prosthetic and orthotic devices are developed for individuals with disabilities.
1919Duderstadt, Lower Saxony, GermanyUSD 17 MUSD 1.97 B–
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of drugs for treating rare and autoimmune diseases
2008Dublin, IrelandUSD 61.78 MUSD 617.41 M–
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M––
Robotic arms are provided for mobility and rehabilitation support.
2004Boston, Massachusetts, United StatesUSD 17.21 MUSD 40.93 M185
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Exoskeletons for medical rehabilitation and industrial productivity are provided.
2005United StatesUSD 24.37 MUSD 71.6 M61
Stabilization devices for healthcare are manufactured by the company.
2005New York, New York, United StatesUSD 142.15 M–43
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DiSanto Technology

DiSanto Technology was founded in 1967.

DiSanto Technology is headquartered in New York, United States. It is registered at New York, New York, United States.

DiSanto Technology has 76 employees.

DiSanto Technology was founded in 1967 in New York, United States, and operates as a contract manufacturer in the medical device sector, focusing on orthopedic and spine markets. Services include new product concept development, prototyping, and refinement of existing products. Expertise encompasses additive manufacturing, electron beam melting, subtractive machining, design engineering, and trabecular modeling. Patient-specific orthopedics are prototyped and produced using electron beam melting technology.

DiSanto Technology's top competitors include Stryker, NuVasive and CARLSMED.

DiSanto Technology has 2 investors. Key investors include Oerlikon, and Arcam.

DiSanto Technology operates through Disanto Technology, Inc..

Yes. DiSanto Technology was acquired by Oerlikon in May 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available